annual cash & cash equivalents:
$98.17M+$44.94M(+84.42%)Summary
- As of today (July 27, 2025), COGT annual cash & cash equivalents is $98.17 million, with the most recent change of +$44.94 million (+84.42%) on December 31, 2024.
- During the last 3 years, COGT annual cash & cash equivalents has fallen by -$121.52 million (-55.32%).
- COGT annual cash & cash equivalents is now -59.47% below its all-time high of $242.19 million, reached on December 31, 2020.
Performance
COGT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$126.00M+$27.84M(+28.36%)Summary
- As of today (July 27, 2025), COGT quarterly cash & cash equivalents is $126.00 million, with the most recent change of +$27.84 million (+28.36%) on March 31, 2025.
- Over the past year, COGT quarterly cash & cash equivalents has dropped by -$89.80 million (-41.61%).
- COGT quarterly cash & cash equivalents is now -61.30% below its all-time high of $325.56 million, reached on June 30, 2022.
Performance
COGT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
COGT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +84.4% | -41.6% |
| 3 y3 years | -55.3% | -34.0% |
| 5 y5 years | +162.3% | +325.6% |
COGT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.3% | +84.4% | -61.3% | +136.7% |
| 5 y | 5-year | -59.5% | +162.3% | -61.3% | +490.4% |
| alltime | all time | -59.5% | +247.2% | -61.3% | +490.4% |
COGT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $126.00M(+28.4%) |
| Dec 2024 | $98.17M(+84.4%) | $98.17M(+1.2%) |
| Sep 2024 | - | $97.05M(+10.0%) |
| Jun 2024 | - | $88.22M(-59.1%) |
| Mar 2024 | - | $215.80M(+305.4%) |
| Dec 2023 | $53.23M(-61.9%) | $53.23M(-38.7%) |
| Sep 2023 | - | $86.81M(-59.5%) |
| Jun 2023 | - | $214.32M(+33.4%) |
| Mar 2023 | - | $160.70M(+14.9%) |
| Dec 2022 | $139.89M(-36.3%) | $139.89M(-0.5%) |
| Sep 2022 | - | $140.57M(-56.8%) |
| Jun 2022 | - | $325.56M(+70.4%) |
| Mar 2022 | - | $191.05M(-13.0%) |
| Dec 2021 | $219.68M | $219.68M(+8.3%) |
| Sep 2021 | - | $202.89M(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $218.10M(-5.5%) |
| Mar 2021 | - | $230.74M(-4.7%) |
| Dec 2020 | $242.19M(+547.2%) | $242.19M(+87.1%) |
| Sep 2020 | - | $129.42M(+506.4%) |
| Jun 2020 | - | $21.34M(-27.9%) |
| Mar 2020 | - | $29.60M(-20.9%) |
| Dec 2019 | $37.42M(-32.8%) | $37.42M(-18.4%) |
| Sep 2019 | - | $45.88M(-17.9%) |
| Jun 2019 | - | $55.86M(+0.3%) |
| Dec 2018 | $55.67M(+96.9%) | $55.67M(+12.9%) |
| Sep 2018 | - | $49.30M(+5.5%) |
| Jun 2018 | - | $46.73M(+81.8%) |
| Mar 2018 | - | $25.70M(-9.1%) |
| Dec 2017 | $28.27M(-31.6%) | $28.27M |
| Dec 2016 | $41.32M | - |
FAQ
- What is Cogent Biosciences, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. annual cash & cash equivalents year-on-year change?
- What is Cogent Biosciences, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
What is Cogent Biosciences, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of COGT is $98.17M
What is the all time high annual cash & cash equivalents for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high annual cash & cash equivalents is $242.19M
What is Cogent Biosciences, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, COGT annual cash & cash equivalents has changed by +$44.94M (+84.42%)
What is Cogent Biosciences, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of COGT is $126.00M
What is the all time high quarterly cash & cash equivalents for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high quarterly cash & cash equivalents is $325.56M
What is Cogent Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, COGT quarterly cash & cash equivalents has changed by -$89.80M (-41.61%)